CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
  • Product Pipeline
    • Collink.3D Bioinks
      • Collink.3D 50
      • Collink.3D 50L
      • Collink.3D 90
    • Gut-on-a-Chip
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Sustainability
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Mar 30, 2017 6:00am EDT

CollPlant Provides Commercial and Operational Update

Nov 08, 2016 9:21am EST

CollPlant Signs Exclusive Distribution Agreement with Arthrex for Vergenix™STR

Oct 19, 2016 3:09am EDT

CollPlant Receives CE Mark for Vergenix™STR for Treatment of Tendinopathy

Aug 17, 2016 1:23pm EDT

CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of Tendinopathy

May 31, 2016 6:14am EDT

CollPlant Receives Chief Scientist's Authorization for a NIS 12 Million Research and Development Projects with Funding of Approximately 50%

Feb 23, 2016 2:33am EST

CollPlant Receives CE Mark for Vergenix™FG Wound Filler

Feb 04, 2016 3:22am EST

CollPlant Reports Positive Final Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

Dec 08, 2015 4:47am EST

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

Nov 30, 2015 3:39pm EST

CollPlant Reports Positive Final Trial Results for Vergenix®FG Wound Filler

Oct 07, 2015 11:04am EDT

CollPlant Announces Completion of Patient Recruitment for Clinical Trial of Vergenix™FG (Flowable Gel) for the Treatment of Chronic Wounds

RSS
  • Prev
    • 1...
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Details

    exploreCollPlant Ltd

    4 Oppenheimer Street
    P.O. Box 4132
    Rehovot 7670104, Israel

    LinkedinLinkedIn YoutubeYoutube TwitterTwitter
    local_phone+972 73 2325600
    local_printshop+972 73 2325602
    mailinfo@collplant.com

     
     

    ® 2025 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20